Current
Research in
Ophthalmology >>

An Extension Study to Evaluate the Safety and Tolerability of Multiple-Dose Intravitreal Injections of rhuFab V2 in Subjects with Neovascular Age-Related Macular Degeneration Who Have Completed the Treatment Phase of a Genentech-Sponsored Phase I or Phase II/III rhuFab V2 Study

Principal Investigator

Ronald Gentile, M.D.

Enrollment Status

Completed

Objective

To Evaluate the safety and tolerability of multiple-dose intravitreal injections of rhuFab V2 in subjects with neovascular age-related macular degeneration. Study results are currently being analyzed. Please visit this webpage next month for the study update. For more information: ClinicalTrials.gov

Home > Current Research > Clinical Trials in Ophthalmology > Results > An Extension Study to Evaluate the Safety and Tolerability of Multiple-Dose Intravitreal Injections of rhuFab V2 in Subjects with Neovascular Age-Related Macular Degeneration Who Have Completed the Treatment Phase of a Genentech-Sponsored Phase I or Phase II/III rhuFab V2 Study